Cryo-Cell International Management
Management criteria checks 2/4
Cryo-Cell International's CEO is David Portnoy, appointed in Aug 2011, has a tenure of 12.75 years. total yearly compensation is $1.87M, comprised of 37.4% salary and 62.6% bonuses, including company stock and options. directly owns 16.82% of the company’s shares, worth $11.33M. The average tenure of the management team and the board of directors is 12.8 years and 7.7 years respectively.
Key information
David Portnoy
Chief executive officer
US$1.9m
Total compensation
CEO salary percentage | 37.4% |
CEO tenure | 12.8yrs |
CEO ownership | 16.8% |
Management average tenure | 12.8yrs |
Board average tenure | 7.7yrs |
CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Feb 29 2024 | n/a | n/a | -US$10m |
Nov 30 2023 | US$2m | US$700k | -US$10m |
Aug 31 2023 | n/a | n/a | US$3m |
May 31 2023 | n/a | n/a | US$2m |
Feb 28 2023 | n/a | n/a | US$3m |
Nov 30 2022 | US$1m | US$620k | US$3m |
Aug 31 2022 | n/a | n/a | US$1m |
May 31 2022 | n/a | n/a | US$2m |
Feb 28 2022 | n/a | n/a | US$2m |
Nov 30 2021 | US$1m | US$620k | US$2m |
Aug 31 2021 | n/a | n/a | US$4m |
May 31 2021 | n/a | n/a | US$4m |
Feb 28 2021 | n/a | n/a | US$4m |
Nov 30 2020 | US$754k | US$602k | US$4m |
Aug 31 2020 | n/a | n/a | US$3m |
May 31 2020 | n/a | n/a | US$4m |
Feb 29 2020 | n/a | n/a | US$3m |
Nov 30 2019 | US$687k | US$602k | US$2m |
Aug 31 2019 | n/a | n/a | US$2m |
May 31 2019 | n/a | n/a | US$1m |
Feb 28 2019 | n/a | n/a | US$2m |
Nov 30 2018 | US$982k | US$547k | -US$855k |
Aug 31 2018 | n/a | n/a | -US$1m |
May 31 2018 | n/a | n/a | -US$659k |
Feb 28 2018 | n/a | n/a | -US$702k |
Nov 30 2017 | US$1m | US$410k | US$2m |
Compensation vs Market: David's total compensation ($USD1.87M) is above average for companies of similar size in the US market ($USD667.63K).
Compensation vs Earnings: David's compensation has increased whilst the company is unprofitable.
CEO
David Portnoy (60 yo)
12.8yrs
Tenure
US$1,869,397
Compensation
Mr. David I. Portnoy has been Co-Chief Executive Officer of Cryo-Cell International, Inc. since August 31, 2011. Mr. Portnoy serves as the President of Focus Financial Corp., a private investment banking a...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Co-CEO | 12.8yrs | US$1.87m | 16.82% $ 11.3m | |
Co-CEO & Director | 12.8yrs | US$1.19m | 11.55% $ 7.8m | |
CFO & VP of Finance | 26yrs | US$307.30k | 0.56% $ 377.2k | |
Chief Information Officer | 12.2yrs | US$432.28k | 1.04% $ 700.9k | |
Medical Director and Member of Medical & Scientific Advisory Board | 5.9yrs | no data | no data |
12.8yrs
Average Tenure
56yo
Average Age
Experienced Management: CCEL's management team is seasoned and experienced (12.8 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman & Co-CEO | 12.8yrs | US$1.87m | 16.82% $ 11.3m | |
Co-CEO & Director | 2.7yrs | US$1.19m | 11.55% $ 7.8m | |
Medical Director and Member of Medical & Scientific Advisory Board | no data | no data | no data | |
Independent Director | 12.8yrs | US$72.34k | 0.62% $ 418.8k | |
Member of Medical & Scientific Advisory Board | no data | US$47.87k | no data | |
Independent Director | 2.7yrs | US$72.34k | 0.38% $ 254.6k |
7.7yrs
Average Tenure
59yo
Average Age
Experienced Board: CCEL's board of directors are considered experienced (7.7 years average tenure).